Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Medical Minute on Key Decisions in HIV Care: Choosing Initial ART in PWH With Transmitted Drug Resistance

In this case example, learn the data and recommendations for initiating ART in a patient with transmitted antiretroviral drug resistance including why many first line ART options can still be considered.
John D. Baxter, MD
Released: January 5, 2022

Information on this Educational Activity

Faculty

John D. Baxter, MD

Professor of Medicine
Division of Infectious Diseases
Department of Pathology
Cooper Medical School of Rowan University
Head, Division of Infectious Diseases
Cooper University Health Care
Camden, New Jersey

John D. Baxter, MD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

Clinical Care Options (CCO) slideset providing expert insights for ART management in complex clinical situations, including extensive previous treatment

Released: September 30, 2022

Linda-Gail Bekker, MBChB, DTM&H, DCH, FCP(SA), PhD Released: September 12, 2022

Expert faculty discuss recent data on weight and cardiometabolic outcomes with HIV treatment, from Clinical Care Options (CCO)

Priscilla Y. Hsue, MD Jens D. Lundgren, MD, DMSc Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Pharmacists: 0.5 contact hours (0.05 CEUs) Released: August 23, 2022 Expired: August 22, 2023
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings